BG104397A - Extended release formulation - Google Patents

Extended release formulation

Info

Publication number
BG104397A
BG104397A BG104397A BG10439700A BG104397A BG 104397 A BG104397 A BG 104397A BG 104397 A BG104397 A BG 104397A BG 10439700 A BG10439700 A BG 10439700A BG 104397 A BG104397 A BG 104397A
Authority
BG
Bulgaria
Prior art keywords
extended release
provides
release formulation
venlafaxine hydrochloride
antidepressant
Prior art date
Application number
BG104397A
Other languages
Bulgarian (bg)
English (en)
Inventor
Deborah M. Sherman
John C. Clark
John U. Lamer
Original Assignee
American Home Products Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25508423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG104397(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Products Corp. filed Critical American Home Products Corp.
Publication of BG104397A publication Critical patent/BG104397A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG104397A 1997-11-05 2000-05-04 Extended release formulation BG104397A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96432897A 1997-11-05 1997-11-05
PCT/US1998/023338 WO1999022724A2 (en) 1997-11-05 1998-11-03 Extended release formulation containing venlafaxin

Publications (1)

Publication Number Publication Date
BG104397A true BG104397A (en) 2001-02-28

Family

ID=25508423

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104397A BG104397A (en) 1997-11-05 2000-05-04 Extended release formulation

Country Status (39)

Country Link
EP (1) EP1028718B1 (sk)
JP (1) JP2001521892A (sk)
KR (1) KR20010031797A (sk)
CN (1) CN1278165A (sk)
AR (1) AR014012A1 (sk)
AT (1) ATE237320T1 (sk)
AU (1) AU747978B2 (sk)
BG (1) BG104397A (sk)
BR (1) BR9813179A (sk)
CA (1) CA2305242A1 (sk)
CL (1) CL2004001705A1 (sk)
CO (1) CO5011060A1 (sk)
CZ (1) CZ20001659A3 (sk)
DE (1) DE69813602T2 (sk)
DK (1) DK1028718T3 (sk)
EA (1) EA200000487A1 (sk)
EE (1) EE04577B1 (sk)
ES (1) ES2196620T3 (sk)
GE (1) GEP20043198B (sk)
HK (1) HK1029056A1 (sk)
HR (1) HRP20000213B1 (sk)
HU (1) HU225238B1 (sk)
ID (1) ID26317A (sk)
IL (1) IL135457A0 (sk)
MA (1) MA24691A1 (sk)
NO (1) NO20002126L (sk)
NZ (1) NZ504460A (sk)
PA (1) PA8462501A1 (sk)
PE (1) PE128699A1 (sk)
PL (1) PL341141A1 (sk)
PT (1) PT1028718E (sk)
SK (1) SK6472000A3 (sk)
SV (1) SV1998000131A (sk)
TR (1) TR200001232T2 (sk)
TW (1) TW555568B (sk)
UA (1) UA77145C2 (sk)
UY (2) UY25234A1 (sk)
WO (1) WO1999022724A2 (sk)
ZA (1) ZA9810081B (sk)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0200898A3 (en) * 1999-04-06 2005-09-28 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
ATE367153T1 (de) * 1999-05-20 2007-08-15 Elan Corp Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
CN1630631A (zh) * 2001-12-05 2005-06-22 惠氏公司 新的文拉法星盐酸盐多晶型物及其制备方法
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
US6696496B2 (en) 2002-03-28 2004-02-24 Synthon Bv Low water-soluble venlafaxine salts
US6717015B2 (en) 2002-03-28 2004-04-06 Synthon Bv Venlafaxine besylate
US20030190351A1 (en) * 2002-03-28 2003-10-09 Synthon Bv Extended release venlafaxine formulations
AR039165A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Venlafaxina base
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
CA2415154C (en) * 2002-12-24 2009-06-16 Biovail Laboratories Inc. Modified release formulations of selective serotonin re-uptake inhibitors
DE10350194B4 (de) * 2003-10-28 2005-11-10 Bioplanta Arzneimittel Gmbh Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
TW200503670A (en) * 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
DK1502587T3 (da) * 2003-07-30 2007-01-02 Pharmathen Sa Formulering med vedvarende frigivelse af venlafaxinhydrochlorid
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
BRPI0418283A (pt) 2004-02-04 2007-05-02 Alembic Ltd formulação de liberação prolongada e processo para a preparação de uma formulação de liberação prolongada
US7776358B2 (en) 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
US20190083399A9 (en) * 2006-04-03 2019-03-21 Isa Odidi Drug delivery composition
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN102772390B (zh) * 2012-08-16 2014-01-08 乐普药业股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
TR200001232T2 (tr) 2000-12-21
CL2004001705A1 (es) 2005-06-03
EP1028718A2 (en) 2000-08-23
HRP20000213B1 (en) 2004-04-30
DE69813602D1 (de) 2003-05-22
NZ504460A (en) 2003-01-31
HK1029056A1 (en) 2001-03-23
UY25234A1 (es) 2000-12-29
AU1300399A (en) 1999-05-24
IL135457A0 (en) 2001-05-20
GEP20043198B (en) 2004-03-25
ES2196620T3 (es) 2003-12-16
UA77145C2 (en) 2006-11-15
PL341141A1 (en) 2001-03-26
AU747978B2 (en) 2002-05-30
NO20002126L (no) 2000-05-04
EA200000487A1 (ru) 2000-10-30
HU225238B1 (en) 2006-08-28
SK6472000A3 (en) 2000-11-07
UY25692A1 (es) 2000-03-31
BR9813179A (pt) 2000-08-22
ID26317A (id) 2000-12-14
AR014012A1 (es) 2001-01-31
SV1998000131A (es) 1999-11-18
TW555568B (en) 2003-10-01
EE04577B1 (et) 2006-02-15
HRP20000213A2 (en) 2000-12-31
ATE237320T1 (de) 2003-05-15
DE69813602T2 (de) 2003-11-06
NO20002126D0 (no) 2000-04-26
PT1028718E (pt) 2003-07-31
EE200000212A (et) 2001-04-16
HUP0004287A3 (en) 2002-05-28
EP1028718B1 (en) 2003-04-16
KR20010031797A (ko) 2001-04-16
CA2305242A1 (en) 1999-05-14
CN1278165A (zh) 2000-12-27
DK1028718T3 (da) 2003-07-28
PA8462501A1 (es) 2000-05-24
PE128699A1 (es) 2000-01-06
CZ20001659A3 (cs) 2001-10-17
WO1999022724A2 (en) 1999-05-14
CO5011060A1 (es) 2001-02-28
WO1999022724A3 (en) 1999-07-22
HUP0004287A2 (hu) 2002-04-29
JP2001521892A (ja) 2001-11-13
ZA9810081B (en) 2000-05-04
MA24691A1 (fr) 1999-07-01

Similar Documents

Publication Publication Date Title
BG104397A (en) Extended release formulation
CA2199778A1 (en) Extended release formulation of venlafaxine
MY126555A (en) Oral pharmaceutical extended release dosage form
NZ333822A (en) Tramadol multiple unit formulations comprising individual pellets of trmadol coated with one or more membrane layers for controlling release
AU6136199A (en) Dosage form comprising therapeutic formulation
IL116674A (en) Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
HK1010835A1 (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
GEP20053501B (en) Core Tablet for Controlled Release of Gliclazide after Oral Administration
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
MX2008006037A (es) Drogas para el sistema nervioso central para administracion una-vez-al-dia.
UA41392C2 (uk) Швидкорозчинна таблетка трамадолу або солі трамадолу
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
ZA985142B (en) Captopril retard.
IL148777A (en) Mirtazepine oral oral administration unit
GEP20043377B (en) Pharmaceutical Complex
AU4469097A (en) Captopril tablets
ECSP982704A (es) Formula de liberacion prolongada
UA83094C2 (en) Tablet of citalopram hydrobromide
CA2225628A1 (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
ES2173023A1 (es) Composicion farmaceutica con actividad inmunosupresora